Compugen Ltd.

8.25-0.0400-0.48%Vol 619.82K1Y Perf -40.41%
Apr 20th, 2021 16:00 DELAYED
BID7.89 ASK8.54
Open8.31 Previous Close8.29
Pre-Market- After-Market8.25
 - -  - -%
Target Price
21.29 
Analyst Rating
Strong Buy 1.00
Potential %
158.06 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★★     57.17
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★     53.16
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap564.47M 
Earnings Rating
Sell
Price Range Ratio 52W %
8.98 
Earnings Date
5th May 2021

Today's Price Range

7.968.47

52W Range

7.1019.90

5 Year PE Ratio Range

-13.10-6.90

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-4.73%
1 Month
-9.34%
3 Months
-34.73%
6 Months
-40.86%
1 Year
-40.41%
3 Years
106.25%
5 Years
17.35%
10 Years
80.62%

TickerPriceChg.Chg.%
CGEN8.25-0.0400-0.48
AAPL133.11-1.7300-1.28
GOOG2 293.63-8.7700-0.38
MSFT258.26-0.4800-0.19
XOM55.29-1.1900-2.11
WFC42.54-1.3400-3.05
JNJ166.483.79002.33
FB302.650.41000.14
GE13.06-0.4000-2.97
JPM149.27-3.3800-2.21
Financial StrengthValueIndustryS&P 500US Markets
12.00
12.30
0.02
0.03
-
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
97.00
-454.60
-454.60
-
-
RevenueValueIndustryS&P 500US Markets
2.00M
0.02
-78.92
-11.11
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.10-0.100.00
Q03 2020-0.09-0.090.00
Q02 2020-0.10-0.0820.00
Q01 2020-0.10-0.100.00
Q04 2019-0.11-0.109.09
Q03 2019-0.11-0.109.09
Q02 2019-0.14-0.1028.57
Q01 2019-0.17-0.1417.65
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.12-9.09Negative
6/2021 QR-0.12-9.09Negative
12/2021 FY-0.51-13.33Negative
12/2022 FY-0.69-23.21Negative
Next Report Date5th May 2021
Estimated EPS Next Report-0.12
Estimates Count6
EPS Growth Next 5 Years %-
Volume Overview
Volume619.82K
Shares Outstanding68.42M
Trades Count6.16K
Dollar Volume38.92M
Avg. Volume1.39M
Avg. Weekly Volume848.81K
Avg. Monthly Volume1.25M
Avg. Quarterly Volume1.42M

Compugen Ltd. (NASDAQ: CGEN) stock closed at 8.25 per share at the end of the most recent trading day (a -0.48% change compared to the prior day closing price) with a volume of 627.84K shares and market capitalization of 564.47M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 68 people. Compugen Ltd. CEO is Anat Cohen-Dayag.

The one-year performance of Compugen Ltd. stock is -40.41%, while year-to-date (YTD) performance is -31.87%. CGEN stock has a five-year performance of 17.35%. Its 52-week range is between 7.1 and 19.9, which gives CGEN stock a 52-week price range ratio of 8.98%

Compugen Ltd. currently has a PE ratio of -24.10, a price-to-book (PB) ratio of 6.22, a price-to-sale (PS) ratio of 358.56, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -30.17%, a ROC of -31.36% and a ROE of -36.78%. The company’s profit margin is -%, its EBITDA margin is -454.60%, and its revenue ttm is $2.00 Million , which makes it $0.02 revenue per share.

Of the last four earnings reports from Compugen Ltd., there were 1 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.12 for the next earnings report. Compugen Ltd.’s next earnings report date is 05th May 2021.

The consensus rating of Wall Street analysts for Compugen Ltd. is Strong Buy (1), with a target price of $21.29, which is +158.06% compared to the current price. The earnings rating for Compugen Ltd. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Compugen Ltd. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Compugen Ltd. has a Sell technical analysis rating based on Technical Indicators (ADX : 22.80, ATR14 : 0.92, CCI20 : -30.94, Chaikin Money Flow : -0.02, MACD : -0.99, Money Flow Index : 66.17, ROC : -3.49, RSI : 36.29, STOCH (14,3) : 44.20, STOCH RSI : 0.43, UO : 51.06, Williams %R : -55.80), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Compugen Ltd. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
7 (100.00 %)
6 (100.00 %)
3 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Compugen Ltd.

Compugen Ltd is a therapeutic discovery company. It is involved in the business of using its predictive discovery infrastructure to identify novel drug targets and develop biologics. The firm's therapeutic pipeline mainly consists of early-stage immuno-oncology programs aimed at harnessing the immune system to fight cancer. It focuses on immune checkpoint target candidates which are predicted to serve drug targets for cancer immunotherapies addressing various cancer types and also autoimmune diseases.

CEO: Anat Cohen-Dayag

Telephone: +972 37658585

Address: 26 Harokmim Street, Holon 5885849, , IL

Number of employees: 68

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

53%47%

Bearish Bullish

58%42%

Bearish Bullish

64%36%

News

Stocktwits